Compare PLUS & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLUS | RXRX |
|---|---|---|
| Founded | 1990 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 1996 | 2021 |
| Metric | PLUS | RXRX |
|---|---|---|
| Price | $95.07 | $3.54 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $7.32 |
| AVG Volume (30 Days) | 219.8K | ★ 21.4M |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | ★ 1.14% | N/A |
| EPS Growth | ★ 24.20 | 14.79 |
| EPS | ★ 2.72 | N/A |
| Revenue | ★ $2,442,549,000.00 | $74,681,000.00 |
| Revenue This Year | $4.67 | N/A |
| Revenue Next Year | $4.89 | $49.16 |
| P/E Ratio | $34.71 | ★ N/A |
| Revenue Growth | 18.07 | ★ 26.92 |
| 52 Week Low | $73.09 | $2.77 |
| 52 Week High | $98.21 | $5.24 |
| Indicator | PLUS | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.64 | 45.11 |
| Support Level | $85.87 | $2.90 |
| Resistance Level | $98.03 | $3.66 |
| Average True Range (ATR) | 4.31 | 0.33 |
| MACD | -0.13 | -0.04 |
| Stochastic Oscillator | 84.64 | 10.50 |
ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.